August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This narrative literature review by Lustrao examines the existing research on six botanical ingredients in their Hair Regrowth Oil, finding varied evidence levels and highlighting rosemary oil's strong human clinical support for hair growth compared to minoxidil.
June 2026 in “Journal of Cosmetic Dermatology” PDRN may help with female hair loss, but more research is needed.
June 2026 in “Revista Brasileira de Saúde” This study reviewed current scientific evidence on how scalp microbiome alterations may affect hair growth, citing connections to inflammatory and immune processes and suggesting potential for therapeutic targeting, though further studies are needed to confirm clinical applications.
June 2026 in “Indian Journal of Research in Homoeopathy” This case series evaluated the effects of individualised homoeopathic treatment on five patients with alopecia areata, finding clinical improvement and new hair growth in those treated with specific remedies like Phosphorus and Tuberculinum.
May 2026 in “Journal of Skin and Sexually Transmitted Diseases” This review highlights the demonstrated efficacy and growing use of upadacitinib for cutaneous disorders, emphasizing its cost-effectiveness and recent availability in India compared to other biologics and small-molecule therapies, rather than providing new primary data.
May 2026 in “Journal of Investigative Dermatology” In this study, genetic factors associated with hirsutism were identified, suggesting that both androgen-dependent and independent mechanisms may contribute to excessive hair growth in women.
April 2026 in “Stem Cell Research & Therapy” This systematic review reports that regenerative medicine therapies, such as conditioned media, platelet-rich fibrin, and stem cells, show promising efficacy and safety in treating androgenetic alopecia, though heterogeneity in study protocols and limited long-term data emphasize the need for further research to optimize these strategies.
April 2026 in “International Journal of Drug Delivery Technology” This review concluded that while topical prostaglandin analogues show some potential in treating androgenetic alopecia, evidence is still limited and no products have regulatory approval.
April 2026 in “International Journal of Homoeopathic Sciences” This case study reports that individualised homoeopathic treatment with Calcarea carbonica led to noticeable improvement in acne vulgaris for a 27-year-old woman over six months, after conventional treatments failed to produce significant results.
March 2026 in “Open MIND” This review evaluates PRP, microneedling, and LLLT for alopecia and telogen effluvium, reporting improvements of 30-40% but offers no new clinical data.
February 2026 in “Acta Dermato Venereologica” In this study, a survey in Norway and Sweden among adults with self-reported alopecia areata revealed a substantial economic burden with annual mean costs of €7,677 in Norway and €12,582 in Sweden, largely due to indirect costs from reduced productivity.
February 2026 in “International Journal of Homoeopathic Sciences” In this case report, a 20-year-old woman with chronic spontaneous urticaria experienced clinical improvement after receiving personalized homeopathic treatment with Natrum muriaticum 1M, underscoring the potential role of individualized homeopathy in managing this condition.
January 2026 in “Cosmetics” This study highlights emerging regenerative strategies, such as stem cell-derived therapies and machine learning tools, that may advance hair loss treatment beyond traditional methods by promoting follicle regeneration and offering personalized care.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that platelet-rich plasma therapy may improve hair density and thickness in androgenetic alopecia, especially in early to moderate stages, though standardization of preparation is needed for consistent results.
January 2026 in “International Journal of Unani and Integrative Medicine” This study evaluated the antiulcer potential of Glycyrrhiza glabra and found that its hydroalcoholic extract demonstrated dose-dependent protective effects against various ulcer models, comparable to standard drugs like omeprazole and cimetidine, by enhancing mucosal defenses and reducing stomach acid production.
December 2025 in “British Journal of Dermatology” January 2025 in “INTERNATIONAL JOURNAL OF CREATIVE RESEARCH THOUGHTS” This article does not present new research findings, but rather lists information about UGC-CARE approved journals and their publication standards, emphasizing qualities like peer review, cost, and impact factor.
January 2025 in “International Journal of Trichology” This study surveyed hair loss practitioners and found that while most view androgenetic alopecia as having pathological features, opinions vary on whether it is a disease or requires treatment.
December 2024 in “Journal of the International Society of Sports Nutrition” In this narrative review, researchers examined common misconceptions and questions about creatine monohydrate, addressing issues such as its potential effects on muscle benefits without exercise, interactions with caffeine, inflammatory properties, safety during pregnancy, and effects on adolescents, among others.
December 2024 in “Health Science Reports” This review found that topical metformin shows potential as a treatment in dentistry for periodontitis and in dermatology for conditions like wound healing and acne, but results for melasma are inconsistent.
November 2024 in “Applied Sciences” This study suggests that while some evidence indicates potential efficacy of placental products for hair growth and inhibiting hair loss, the current scientific evidence is scarce and of low quality.
This systematic review reports positive outcomes for platelet-rich plasma in aesthetic dermatology applications like skin rejuvenation, hair restoration, wound healing, and fat grafting, but highlights the need for standardized protocols in future research.
In their review, the authors found no strong evidence supporting biotin's effectiveness as a hair supplement, noting a significant disparity between its popularity and scientific backing, with available studies showing no substantial benefit over placebo.
July 2024 in “Clinical and Experimental Dermatology” This study found distinct hair loss patterns among 112 women with female pattern hair loss, identifying unique presentations specifically in Asian, including South Asian, and Black women, which may influence treatment response across different racial groups.
June 2024 in “Georgetown Scientific Research Journal” This study found that intradermal bleomycin injections induced dermal fibrosis in C57BL/6 mice, evidenced by hair follicle obliteration and dermal thickening, though no significant trends in gene expression were observed, indicating the need for further research to understand the link between fibrosis and dyschromia.
May 2024 in “Reproductive BioMedicine Online” This systematic review found that interactions between patients with polycystic ovary syndrome and healthcare professionals often face challenges due to insufficient information sharing, inadequate patient support, and health system barriers.
November 2023 in “The journal of investigative dermatology/Journal of investigative dermatology” In this study, researchers found that ex vivo and in vivo administration of the TYK2 inhibitor BMS-986202 prevented immune privilege collapse and promoted hair regrowth in models of alopecia areata, suggesting this approach may offer a new therapeutic avenue deserving of clinical investigation.
August 2023 in “Journal of Natural Remedies” This review highlights the bioactive compounds in the brown seaweeds Undaria pinnatifida (wakame) and Saccharina japonica (kombu), detailing their various health benefits based on clinical studies, notably from Japan and elsewhere.
January 2023 in “International Journal of Homoeopathic Sciences” This case report describes a 14-year-old girl with alopecia areata who experienced hair restoration following homeopathic treatment aimed at balancing her immune system over a 6-month follow-up.
September 2022 in “Medical Herald of the South of Russia” This article discusses the effectiveness of gender transition procedures in alleviating gender dysphoria and the need for better models to understand their mechanisms, but reports no new clinical results.